Professor Robert Perneczky emphasizes the importance of brain reserve against neurodegeneration and dementia.
Brain reserve in Alzheimer’s disease
Professor Perneczky is on the advisory board for Biogen, has consulted for Eli Lilly, is a grant recipient from Janssen Pharmaceutica and Boehringer Ingelheim, and has received speaker honoraria from Janssen-Cilag, Pfizer and Biogen.